These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24597954)

  • 1. Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.
    Mao Y; Poschke I; Kiessling R
    J Intern Med; 2014 Aug; 276(2):154-70. PubMed ID: 24597954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-27 in tumor immunity and immunotherapy.
    Murugaiyan G; Saha B
    Trends Mol Med; 2013 Feb; 19(2):108-16. PubMed ID: 23306374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
    Braster R; O'Toole T; van Egmond M
    Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate cell communication kick-starts pathogen-specific immunity.
    Rivera A; Siracusa MC; Yap GS; Gause WC
    Nat Immunol; 2016 Apr; 17(4):356-63. PubMed ID: 27002843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immune mediators in cancer: between defense and resistance.
    Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
    Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes.
    Duechler M; Peczek L; Zuk K; Zalesna I; Jeziorski A; Czyz M
    Immunobiology; 2014 Feb; 219(2):158-65. PubMed ID: 24091277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are macrophages, myeloid derived suppressor cells and neutrophils mediators of local suppression in healthy and cancerous tissues in aging hosts?
    Jackaman C; Nelson DJ
    Exp Gerontol; 2014 Jun; 54():53-7. PubMed ID: 24291067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into chronic inflammation-induced immunosuppression.
    Kanterman J; Sade-Feldman M; Baniyash M
    Semin Cancer Biol; 2012 Aug; 22(4):307-18. PubMed ID: 22387003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the anti-tumour immune response by cancer-associated fibroblasts.
    Harper J; Sainson RC
    Semin Cancer Biol; 2014 Apr; 25():69-77. PubMed ID: 24406209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune processes are sufficient for driving cigarette smoke-induced inflammation in mice.
    Botelho FM; Gaschler GJ; Kianpour S; Zavitz CC; Trimble NJ; Nikota JK; Bauer CM; Stämpfli MR
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):394-403. PubMed ID: 19502389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cells that mediate innate immune memory and their functional significance in inflammatory and infectious diseases.
    Gardiner CM; Mills KH
    Semin Immunol; 2016 Aug; 28(4):343-50. PubMed ID: 26979658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of innate immunity in organ transplantation part III: the quest for transplant tolerance via prevention of oxidative allograft injury and its consequences.
    Land WG
    Transplant Rev (Orlando); 2012 Apr; 26(2):88-102. PubMed ID: 22000661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory Role of Myeloid-derived Cells in Inflammatory Bowel Disease.
    Leal MC; Däbritz J
    Inflamm Bowel Dis; 2015 Dec; 21(12):2936-47. PubMed ID: 26244650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid suppressor cells regulate the adaptive immune response to cancer.
    Frey AB
    J Clin Invest; 2006 Oct; 116(10):2587-90. PubMed ID: 17016554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity.
    Kim R; Emi M; Tanabe K
    Immunology; 2006 Oct; 119(2):254-64. PubMed ID: 17005005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H; Marshall NA; Mills KH
    Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cell role in tumor-related inflammation.
    Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
    Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
    Marigo I; Dolcetti L; Serafini P; Zanovello P; Bronte V
    Immunol Rev; 2008 Apr; 222():162-79. PubMed ID: 18364001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour immunotherapy--leukocytes take up the fight.
    Alderton GK; Bordon Y
    Nat Rev Immunol; 2012 Apr; 12(4):237. PubMed ID: 22545289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy.
    Hussain M; Javeed A; Ashraf M; Al-Zaubai N; Stewart A; Mukhtar MM
    Pharmacol Res; 2012 Jul; 66(1):7-18. PubMed ID: 22449788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.